๐ฐ Process Validation News
Process Validation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Process Validation. Real-time updates on events, politics, business and more.
May 28, 2024
This article talks about adopting process analytical technologies in the biopharmaceutical industry.
March 12, 2024
12.03.2024 - Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) - Glucotrack, Inc. (Nasdaq: GCTK) (โGlucotrackโ or the โCompanyโ), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, ... Seite 1
January 17, 2024
From the inception of a concept to the watchful eye that oversees post-market vigilance, quality assurance remains the sentinel of safety and efficacy.
October 20, 2023
Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients T-cells to recognize and attack cancer
March 17, 2023
/PRNewswire/ -- The "Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) Workshop" training has been added to...
February 21, 2023
/PRNewswire/ -- The "Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to...
January 17, 2023
ASTM has published the revision of ASTM E3263 "Standard Practice For Qualification Of Visual Inspection Of Pharmaceutical Manufacturing...
December 5, 2022
DUBLIN--(BUSINESS WIRE)--The "Effective Technology Transfer Training Course" conference has been added to ResearchAndMarkets.com's offering.Technology transfer (TT) is an increasingly important part of the pharmaceutical industry, with companies expanding the use of third parties for both development and manufacture...
October 20, 2022
/PRNewswire/ -- The "Effective Technology Transfer Training Course" conference has been added to ResearchAndMarkets.coms offering. Technology transfer (TT) is...
October 11, 2022
To ensure that a commercial biomanufacturing process is in a state of control, life science companies must create and successfully execute initiatives to meet continued process verification (CPV) and other monitoring guidelines.